Physician profile
Anders Mellgren
NPI 1053320671
$10,098.17
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,850 · 2020: $831 · 2021: $1,252 · 2022: $645 · 2023: $359 · 2024: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,141.52 | 2019-2022 | |
| Allergan, INC. | $1,128.75 | 2019-2021 | |
| Davol INC. | $550.68 | 2019-2022 | |
| Medtronic, INC. | $531.01 | 2021-2023 | Signet, Interstim |
| Axonics, INC. | $361.57 | 2021 | |
| Cook Biotech Incorporated | $314.33 | 2022-2023 | Biodesign |
| Medtronic USA, INC. | $241.62 | 2019 | |
| Medical Device Business Services, INC. | $239.65 | 2021-2024 | Enseal |
| Pacira Pharmaceuticals Incorporated | $153.18 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $120.30 | 2019 | |
| Conmed Corporation | $100.00 | 2019 | |
| Baxter Healthcare | $99.34 | 2022 | |
| Palette Life Sciences, INC. | $93.30 | 2020-2022 | |
| Teleflex LLC | $22.92 | 2024 | Solesta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anders Mellgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.